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Salivary gland tumors displaying exclusively myoepithelial differentiation are
referred to as myoepitheliomas. Myoepitheliomas are rare tumors that account for
less than 1% of all salivary gland tumors.
1,2 There seems to be a range of
differentiation among the myoepitheliomas, with both benign and malignant
variants represented. The majority of myoepitheliomas reported in the literature
have been benign, and approximately 50 malignant myoepithelioma cases have
been reported in the English literature, mostly as single case reports.
3 The rarity
contrasts with the active role of myoepithelial cells in the histogenesis of several
types of salivary gland tumors.
4 It seems that malignant myoepitheliomas have
been underrecognized in the past and are probably not as rare as previously
thought.
3 A malignant myoepithelioma may arise de novo or develop within a
preexisting pleomorphic adenoma or benign myoepithelioma.
1,5,6 Similarly to
benign myoepitheliomas, the parotid gland is the most common primary site and
the palate the most common intra-oral site of occurrence.
3,7
In this report, a case of a malignant myoepithelioma arising in a 79-year-old
woman is presented, and the clinicopathological and immunohistochemical
aspects of such tumors is discussed.
A 79-year-old woman presented with a 4-month history of a painless swelling in
the hard palate. The swelling had gradually increased in size over the last two
months. The lesion had been examined by biopsy at another hospital, and diagnosed
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INTRODUCTION
CASE REPORTas a poorly differentiated squamous cell carcinoma. The
biopsy specimen was reviewed at our hospital, and the
tumor diagnosed as a poorly differentiated carcinoma.
Oral examination revealed a 3×4 cm firm, painless,
submucosal mass located in the hard palate and overlying
mucosa was ulcerated. There was no regional lympha-
denopathy. The remainder of her physical examination
was otherwise normal and laboratory studies showed no
abnormalities. Magnetic resonance imaging of the head
and neck region revealed a solid mass in the hard palate
(Fig. 1). The tumor was removed using a transoral approach
under general anesthesia. The lesion was mapped with an
adequate margin of 1 cm and the incision included the
periosteum. No invasion was seen on the periosteum and
bone. The defect was covered with a dermal graft.
The postoperative course of the patient was uncom-
plicated, and she was discharged on the 12th postoperative
day. Five months after the operation, the patient is well
without evidence of recurrence or metastasis. 
Pathological findings
Macroscopically, the tumor was 3×4 cm in size and unen-
capsulated. The overlying mucosa was ulcerated. The cut
surface of the tumor was solid and tan-white, with punctate
yellowish foci. Microscopically, the tumor was composed
of a mixture of two distinct neoplastic cell populations.
The predominant population was composed of large
polyhedral cells with eosinophilic cytoplasm and eccentric,
round nuclei (Fig. 2). The cells had a distinct plasmacytoid
appearance. The nuclei were generally large, hyperchro-
matic and pleomorphic, and contained prominent nucleoli.
The cells were arranged in either sheets or as loose aggre-
gates lying in a myxoid matrix. The mitotic rate was 18
mitoses per 10 high power fields (HPFs) and atypical
mitotic figures were also observed. The second population
was seen in focal areas and consisted of spindle, fibroblast-
like cells with elongated nuclei. The cells formed bundles
and showed less pleomorphism than the plasmacytoid
cells. There were small foci of necrosis. No perineural and
vascular invasions were observed. Noncohesive, infiltrative
single tumor cells were seen at the edge of the tumor (Fig.
3). The surgical margins were free of disease.  
Immunohistochemical findings        
The tumor cells were strongly and diffusely positive for
vimentin (Neomarkers, Fremont, CA, USA) and S-100
protein (Novocastra, Newcastle, UK) (Fig. 4). Large num-
bers of tumor cells were immunoreactive for cytokeratin
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Fig. 2. Plasmacytoid and spindle-shaped cells, with pleomorphic nuclei and
prominent nucleoli in a myxomatous stroma (H&E, original magnification×200). 
Fig. 1.Axial computed tomography scan showing a solid mass in the hard palate.
Fig. 4. (A) Tumor cells were diffusely and intensely positive for vimentin (original
magnification×200) and (B) S-100 protein (original magnification×200).
Fig. 3. Noncohesive, infiltrative and widespread single tumor cells at the edge of
the tumor (H&E, original magnification×100).
B A(Neomarkers). Epithelial membrane antigen (Neomarkers),
smooth muscle actin (Novocastra) and glial fibrillary acidic
protein (Dako, Carpinteria, CA, USA) were also expressed
focally. The tumor cells were negative for desmin (Novo-
castra) and HMB-45 (Neomarkers). The Ki-67 (using the
mAb MIB-1, Novocastra) labeling index was 17%.                
Malignant myoepithelioma is one of the rarest salivary
gland neoplasms. It was first described by Stromeyer et al.
8
in 1975 and approximately 50 cases have subsequently
been reported in the English literature.
3 Malignant myoe-
pithelioma was included in the updated histological
classification of salivary gland tumors by the World Health
Organization in 1991.
9
Patients with malignant myoepithelioma are generally
aged over 50 years
1,3 and the majority presents with a
painless mass as the primary complaint.
3 The parotid gland
is the most common primary site,
1,3 followed by the
submandibular gland and minor salivary glands.
10,11 The
palate is the most common intraoral site of occurrence.
3,7
Grossly, these tumors are generally soft to slightly firm
and unencapsulated. They have infiltrative tumor borders
with destructive tumor extensions into the adjacent salivary
gland or surrounding tissues.
3 The tumor cells in malignant
myoepithelioma patients show a wide variety of morpho-
logy, comprising of spindle, plasmacytoid (hyaline),
epithelioid and clear cell subtypes and combinations of
these cell types may be present within the same tumor. In
malignant myoepitheliomas, two different tumor-related
matrices have been described: myxoid and hyalinized. In
some malignant myoepithelioma cases metaplastic changes
have been noted,
1,3 including squamous, chondroid and
sebaceous metaplasia. Immunohistochemically, the com-
bined expressions of myoepithelial markers, such as
vimentin, S-100 protein, glial fibrillary acidic protein and
smooth muscle actin, in addition to cytokeratins, are char-
acteristic.
1,12
To establish the diagnosis of a malignant myoepi-
thelioma, two histologic criteria must be satisfied: the neo-
plastic cells must show exclusively myoepithelial differen-
tiation and the tumor must exhibit malignant features.
5,10,12
In our case, the immunoreactivities of the tumor cells for
S-100 protein, cytokeratins, vimentin, glial fibrillary acidic
protein (GFAP), and smooth muscle actin were in
agreement with a myoepithelial phenotype. Additionally,
the lack of ductal and acinar differentiation also supported
the diagnosis of a myoepithelial tumor. Increased mitotic
activity, cellular pleomorphism and necrotic areas, and
more importantly, an infiltrative and destructive growth
pattern favored the diagnosis of malignancy.
The differential diagnosis of a malignant myoepithelioma
depends on the predominant cell type. Plasmacytoid cell
type malignant myoepitheliomas should be distinguish
from a plasmacytoma, malignant melanoma and large cell
lymphoma. For the spindle cell type, the differential diag-
nosis includes hemangiopericytoma, schwannoma, fibro-
sarcoma, leiomyosarcoma and malignant peripheral nerve
sheath tumor. Immunohistochemical staining is helpful in
differentiating these lesions. A malignant myoepithelioma
should also be distinguish from its benign counterpart. The
histological features considered helpful in discriminating
benign and malignant myoepitheliomas include cytologi-
cal atypia, mitotic activity, infiltrative growth pattern and
necrosis.
1,11,13,14 Savera, et al.
3 emphasized that the minimum
requirement for the diagnosis of a malignant myoepi-
thelioma is the presence of tumor infiltration into the
adjacent tissues. Recently, it has been shown that more
than seven mitoses per 10 HPFs or a Ki-67 labeling index
of more than 10% is diagnostic of malignant myoepithel-
ioma.
1 In the oral region, distinction between a malignant
myoepithelioma and spindle cell or poorly differentiated
squamous cell carcinoma can be challenging, especially
with small biopsy specimens. In our case, the lesion had
been examined by biopsy at another hospital, and diagn-
osed as a poorly differentiated squamous cell carcinoma.
However, examination of the resection specimen showed
characteristic histopathological and immunohistochemical
features of a malignant myoepithelioma.
The clinical and biological behavior of these tumors is
variable. There are no definite histological features that
correlate clearly with their behavior. The influence of
various parameters (tumor size, site, cell type, cytologic
grade, presence of underlying benign tumor, mitotic rate,
necrosis, perineural and vascular invasion) on the prog-
nosis was studied by Savera, et al.,
3 and they found cytolo-
gic atypia correlated weakly with a poor outcome, but
none of the other factors showed a significant correlation.
Similarly, Nagao, et al.
1 observed no apparent association
between the cell types and clinical behavior of malignant
myoepitheliomas. The prognostic implication of the
histogenesis of malignant myoepitheliomas is controver-
sial. Nagao, et al.
1 found no differences in the outcome
with regard to the presence or absence of a pre-existing
pleomorphic adenoma, while Di Palma and Guzzo
13
considered a malignant myoepithelioma as a low grade
malignancy, characterized by multiple recurrences and a
long clinical history when arising from a pleomorphic
adenoma, but tend to be more aggressive and have a short
clinical history when arising de novo. Nagao, et al.
1
showed that high proliferative activity, extensive invasion
into the surrounding tissues, perineural permeation and
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DISCUSSIONmarked cellular pleomorphism were correlated with a poor
prognosis.
There is little information about the treatment of these
tumors to date, however, wide surgical excision is accepted
as the appropriate treatment modality. Therapeutic neck
dissection is indicated when there are clinically or radio-
logically apparent metastases in the cervical lymph nodes.
4
Although the value of radiotherapy is unknown, it may be
useful in patients with higher-stage and higher-grade
neoplasms.
15
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